IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Quoin Pharmaceuticals LT (QNRX)

CUSIP: 74907L409 | US | Healthcare · Biotechnology | Micro Cap | 29 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AIkarian Capital, LLC211,5384.4%Newly reportedSep 30, 2026211,538 sh (Jun 30, 2026)
13G/AIkarian Capital, LLC

Institutional Holders — Q3 2026

Aigh Capital Management LLC236,234
0.1% of portfolio›$1.1M
Gamma Investing LLC3,116
0.0% of portfolio›$14.2K
SBI Securities Co., Ltd.128
0.0% of portfolio›$584
Caitong International Asset Management Co., Ltd9
0.0% of portfolio›$41
Nisa Investment Advisors, LLC4
0.0% of portfolio›$18
StyleTurnoverLocationFiled
Aigh Capital Management LLC
236,234$1.1M0.1%GARPVery HighBaltimore, MD2026-11-02
Gamma Investing LLC
3,116$14.2K0.0%IndexVery LowFoster City, CA2026-10-08
SBI Securities Co., Ltd.
128$5840.0%Agg GrowthLowTokyo, Mexico2026-10-22
Caitong International Asset Management Co., Ltd
9$410.0%GrowthVery HighHong Kong, South Korea2026-10-29
Nisa Investment Advisors, LLC
4$180.0%IndexVery LowSt. Louis, MO2026-10-20
211,538
4.4% of class · Sep 30, 2026Newly reported
211,538 sh (Jun 30, 2026)